The Structural Genomics Consortium (SGC) catalyses research in new areas of human biology and drug discovery by focusing on less well-studied areas of the human genome. The SGC accelerates research output available to the scientific community with no strings attached and by creating an open collaborative network of scientists in hundreds of universities around the world and in nine global pharmaceutical companies. Together, the network of academic and industry scientists is driving a new ecosystem whose primary aim is to advance science and is less infucenced by personal, institutional, or commercial gain. The SGC uses an open forum for easy access to continue science. The goal is discovery of new biological, chemical, and technical applications to advance science of the human genome.
Type of Material:
Learning Object Repository
Recommended Uses:
Lecture
Flipped classroom
Homework
Team activity
Professional presentations
Technical Requirements:
Internet access
Accessed with Chrome
Identify Major Learning Goals:
Learners will
describe how SGC and MSD discovered MRK-740, a protent inhibitor of PRDMP.
describe how SGC and collaborators work to create open research tools for Alzheimer’s disease research funded by National Institute on Aging.
discuss what the EUbOPEN consortium, which consists of 22 partners, that will work together to develop high quality chemical tools is working to accomplish.
explain the Rapidly Emerging Antiviral Drug Development Initiative (READDI), a global organization formed to discover and develop drugs to put “on the shelf” for clinical trial testing in anticipation of future viral pandemics.
describe the SGC and collaborating institutions partnership to develop openly distributed tools to test the efficacy of Alzheimer’s therapies.
Target Student Population:
College Upper Division
Graduate School
Professional
Prerequisite Knowledge or Skills:
The biological, chemical, and technical science is difficult to follow without prior courses in the human genome.
Content Quality
Rating:
Strengths:
The content is valid/accurage/reliable as shown by the SGC's parntners and large governmental grants.
The information depicts advancing reality in finding treatments for disease conditions and pandemics.
The information is more for research than for teaching.
The content is difficult to understand without having a background in science. Including definitions of terms would improve the resource.
Potential Effectiveness as a Teaching Tool
Rating:
Strengths:
The potential for learning is enhanced with this material.
The content is the latest research to health practice concerns like the pandemic and Alzheimer's.
Conepts are clear for those who have a background in genomics.
This information is very innovative and engaging.
Concerns:
The website could be enhanced with interactivity.
The website could be improved with definitions of terms.
Ease of Use for Both Students and Faculty
Rating:
Strengths:
The site is robust and in working order.
The site is easy to access and navigate.
The information is clearly designed.
Creative Commons:
Search by ISBN?
It looks like you have entered an ISBN number. Would you like to search using what you have
entered as an ISBN number?
Searching for Members?
You entered an email address. Would you like to search for members? Click Yes to continue. If no, materials will be displayed first. You can refine your search with the options on the left of the results page.
Searching for Members?
You entered an email address. Would you like to search for members? Click Yes to continue. If no, materials will be displayed first. You can refine your search with the options on the left of the results page.
